Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and …

DA van Schalkwyk, S Pratt, D Nolder… - Clinical Infectious …, 2024 - academic.oup.com
Background Recent cases of clinical failure in malaria patients in the United Kingdom (UK)
treated with artemether-lumefantrine have implications for malaria chemotherapy worldwide …
被引用次数：7 相关文章

Treatment failure in a UK malaria patient harbouring genetically variant Plasmodium falciparum from Uganda with reduced in vitro susceptibility to artemisinin and …

DA van Schalkwyk, S Pratt, D Nolder… - Clinical Infectious …, 2023 - ora.ox.ac.uk
Background: Recent cases of clinical failure in UK malaria patients treated with artemether-
lumefantrine have implications for malaria chemotherapy worldwide. Methods: Parasites …

Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and …

DA van Schalkwyk, S Pratt, D Nolder… - … publication of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Recent cases of clinical failure in malaria patients in the United Kingdom (UK)
treated with artemether-lumefantrine have implications for malaria chemotherapy worldwide …

Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and …

DA van Schalkwyk, S Pratt, D Nolder… - … Diseases: an Official …, 2024 - europepmc.org
Background Recent cases of clinical failure in malaria patients in the United Kingdom (UK)
treated with artemether-lumefantrine have implications for malaria chemotherapy worldwide …
[HTML] nih.gov

[HTML][HTML] Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to …

DA van Schalkwyk, S Pratt, D Nolder… - … Diseases: An Official …, 2024 - ncbi.nlm.nih.gov
Background Recent cases of clinical failure in malaria patients in the United Kingdom (UK)
treated with artemether-lumefantrine have implications for malaria chemotherapy worldwide …
[HTML] oup.com

[HTML][HTML] Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to …

DA van Schalkwyk, S Pratt, D Nolder… - Clinical Infectious …, 2024 - academic.oup.com
Background Recent cases of clinical failure in malaria patients in the United Kingdom (UK)
treated with artemether-lumefantrine have implications for malaria chemotherapy worldwide …

Treatment failure in a UK malaria patient harbouring genetically variant Plasmodium falciparum from Uganda with reduced in vitro susceptibility to artemisinin and …

DA van Schalkwyk, S Pratt, D Nolder… - … Diseases: an Official …, 2023 - europepmc.org
Recent cases of clinical failure in UK malaria patients treated with artemether-lumefantrine
have implications for malaria chemotherapy worldwide. Parasites were isolated from an …